Alpha-9 Oncology Appoints Paul Blanchfield as Chief Executive Officer [Yahoo! Finance]
Lantheus Holdings, Inc. (LNTH)
Last lantheus holdings, inc. earnings: 2/25 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.lantheus.com/investor-relations
Company Research
Source: Yahoo! Finance
developing targeted cancer therapies, today announced the appointment of Paul Blanchfield as Chief Executive Officer and a member of the Board of Directors. Mr. Blanchfield brings more than 15 years of diverse leadership experience across radiopharmaceuticals, biotechnology, and healthcare - most recently as President of Lantheus, where he oversaw Commercial, R&D, Medical, and Technical Operations. Alpha-9 Oncology, Inc. (PRNewsfoto/Alpha-9 Oncology, Inc.) "Paul brings exceptional operational experience and deep industry expertise in radiopharma - making him an ideal fit to lead our team at this pivotal moment," said Patrick Heron, Chairman of the Board, Alpha-9 Oncology. "His experience in building and leading commercial and scientific organizations positions him to guide Alpha-9 through its next phase of growth as we advance our clinical programs." Alpha-9 Oncology is focused on differentiated, highly targeted radiopharmaceuticals that deliver radiation directly to tumor cells
Show less
Read more
Impact Snapshot
Event Time:
LNTH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LNTH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LNTH alerts
High impacting Lantheus Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
LNTH
News
- Lantheus to Present Florbetaben F 18 Data at CTAD 2025GlobeNewswire
- Lantheus (LNTH): Buy, Sell, or Hold Post Q3 Earnings? [Yahoo! Finance]Yahoo! Finance
- The Bottom Fishing Club - Lantheus Holdings: Interesting Buy Momentum Supporting Price [Seeking Alpha]Seeking Alpha
- Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know [Yahoo! Finance]Yahoo! Finance
- Investors who lost money on Lantheus Holdings, Inc. (LNTH) should contact The Gross Law Firm about pending Class Action - LNTHGlobeNewswire
LNTH
Earnings
- 11/6/25 - Beat
LNTH
Sec Filings
- 11/26/25 - Form 144
- 11/19/25 - Form 4
- 11/14/25 - Form 144
- LNTH's page on the SEC website